chr8-71271835-G-A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000503.6(EYA1):c.889C>T(p.Arg297*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000503.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- branchio-oto-renal syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- branchiootorenal syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- branchiootic syndrome 1Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- branchiootic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EYA1 | NM_000503.6 | c.889C>T | p.Arg297* | stop_gained | Exon 10 of 18 | ENST00000340726.8 | NP_000494.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Branchiootic syndrome 1 Pathogenic:1
PVS1, PM2, PP3, PP4 -
EYA1-related disorder Pathogenic:1
The EYA1 c.889C>T variant is predicted to result in premature protein termination (p.Arg297*). This variant was reported in multiple individuals with branchio-oto-renal syndrome (described as R265X, Rickard et al. 2000. PubMed ID: 10991693; described as R264X, Fukuda et al. 2001. PubMed ID: 11683347; Feng et al. 2021. PubMed ID: 34868248). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in EYA1 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Melnick-Fraser syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg297*) in the EYA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYA1 are known to be pathogenic (PMID: 10464653, 18220287). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with branchiootorenal and/or branchiootic syndrome (PMID: 10991693, 11683347; Invitae). It has also been observed to segregate with disease in related individuals. This variant is also known as c.790C>T. ClinVar contains an entry for this variant (Variation ID: 429912). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
The R297X nonsense variant in the EYA1 gene has been published (as R265X, R264X, and R297X) in association with branchiootorenal syndrome (Rickard et al., 2000; Orten et al., 2008; Wang et al., 2012). This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Additionally, the R297X variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Therefore, the R297X variant is pathogenic. -
Branchiootic syndrome 1;C3714941:Otofaciocervical syndrome 1;C4551702:Branchiootorenal syndrome 1 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at